Anti-tumor Drug Market Size, share 2018 Industry Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Global Industry Forecast to 2023

Posted on Aug 13 2019 9:09 PM

"The output value of the pharmaceutical industry maintained a growth rate of 20% during the 12th Five-Year Plan period. In 2013, the total output value of the pharmaceutical industry reached 2.1 trillion yuan. However, compared with the bio-pharmaceutical industry in the advanced countries in the world, there is still a huge gap between the biomedical industry in our country and the demand for building an overall well-to-do society. Mainly manifested in: small-scale enterprises, more than 10 billion yuan enterprises and more than one billion yuan less; independent innovation ability is weak, many varieties of imitation with independent intellectual property rights of the few species; restrict some of the long-term development of biomedical industry , Deep-seated problems still exist."

Report Name: - “2018-2023 Global Anti-tumor Drug Market Report (Status and Outlook)”

According to recent analysis, A Global Anti-tumor Drug market report provides in-depth unique Insights with Size, Share, Trends, Scope, Growth, Manufacturers, Suppliers, Distributors, Traders, Customers, Investors and Major Types as well as Applications and Forecast Period (2018 – 2023)Anti-tumor Drug report provides a unique tool for evaluating the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making.

Anti-tumor Drug Market Overview:-

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.In China, antitumor drugs are also the key areas of concern for many enterprises. Such as Jiangsu Hengrui, Qilu Pharmaceutical and other well-known domestic enterprises in the anti-tumor drugs have invested a lot of money, 
There are many innovative anti-cancer drugs into the clinical research stage. In the meantime, there has been "explosive" growth in the development of molecularly targeted drugs, with at least hundreds of drugs under development, and it is conceivable that the market will be quite crowded in the next five to 10 years. Therefore, domestic enterprises should fully understand the feasibility of the project and the fierce market competition that they may face in the future.

China's bio-pharmaceutical industry already has a good foundation; from the national level to local governments at all levels continue to step up efforts to support the development of bio-pharmaceutical industry.

Over the next five years, () projects that Anti-tumor Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

Request a sample copy of the report @

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-tumor Drug market by product type, application, key manufacturers and key regions.

Anti-tumor Drug market Top Key Players:


  • Roche
  • Novartis
  • Celgene
  • Bristol-Myers Squibb
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Astellas
  • Merck & Co
  • Sanofi
  • Bayer
  • Biogen Idec
  • Eisai
  • Teva
  • Otsuka


Anti-tumor Drug Production Breakdown Data by Top Region:

  • United States (Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Russia, Spain)
  • APAC (China, Japan, Korea, Australia)
  • Africa (Egypt, Israel, Turkey)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyses key emerging trends and their impact on present and future development.

By the product type, the Anti-tumor Drug market is primarily split into:


  • Cytotoxic Drugs
  • Non-cytotoxic Drugs


By the end users/application, Anti-tumor Drug market report covers the following segments:


  • Alkylating Agents
  • Anti-metabolism Drugs
  • Platinum Antineoplastic Agents
  • Anthracycline antitumor drugs
  • Microtubule Stabilizer
  • Endocrine Therapy Drugs
  • Immunotherapy Drugs
  • Gene Therapy Drugs
  • Targeted Antineoplastic Drugs


Fill the Pre-Order Enquiry form for the report @

The study objectives of this report are:

  • To study and analyze the global Anti-tumor Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2018, and forecast to 2023.
  • To understand the structure of Anti-tumor Drug market by identifying its various sub segments.
    Focuses on the key global Anti-tumor Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Anti-tumor Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Anti-tumor Drug submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In the end, Anti-tumor Drug market report undertakes the new project, key development areas, business overview, product specification, SWOT analysis, investment feasibility analysis, return analysis, and development trends. The study also presents a round-up of exposures which companies operating in the market and must be avoided in order to enjoy bearable growth through the course of the forecast period.

Purchase this report (Price 4660 USD for a single-user license) @

About 360 Research Reports:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us: -

360 Research Reports

Mr. Ajay More

USA : +1 424 253 0807

UK : +44 203 239 8187

[email protected]